123 related articles for article (PubMed ID: 9804494)
1. Effectiveness of low dose urokinase on dialysis catheter thrombolysis.
Seddon PA; Hrinya MK; Gaynord MA; Lion CM; Mangold BM; Bruns FJ
ASAIO J; 1998; 44(5):M559-61. PubMed ID: 9804494
[TBL] [Abstract][Full Text] [Related]
2. Chronic and acute consequences of a post-dialysis urokinase lock on permanent hemodialysis catheter function.
Gabutti L; Mosconi E; Pellegrini L; Duchini F; Marone C
J Nephrol; 2006; 19(2):183-8. PubMed ID: 16736417
[TBL] [Abstract][Full Text] [Related]
3. High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters.
Twardowski ZJ
Am J Kidney Dis; 1998 May; 31(5):841-7. PubMed ID: 9590195
[TBL] [Abstract][Full Text] [Related]
4. Prospective Audit to Study urokinaSe use to restore Patency in Occluded centRal venous caTheters (PASSPORT 1).
Kumwenda MJ; Mitra S; Khawaja A; Inston N; Nightingale P
J Vasc Access; 2019 Nov; 20(6):752-759. PubMed ID: 31466489
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study.
Al-Ali F; Hamdy AF; Hamad A; Elsayed M; Zafar Iqbal Z; Elsayed A; Ibrahim R; Tolba H; Buanan H; Fawzy A
Nephrol Dial Transplant; 2018 Apr; 33(4):619-626. PubMed ID: 29106676
[TBL] [Abstract][Full Text] [Related]
6. Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis.
Eyrich H; Walton T; Macon EJ; Howe A
Am J Health Syst Pharm; 2002 Aug; 59(15):1437-40. PubMed ID: 12166043
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of urokinase lock to treat thrombotic dysfunction of tunneled hemodialysis catheters: A retrospective cohort study.
Van Hulle F; Bonkain F; De Clerck D; Aerden D; Vanwijn I; Tielemans C; Wissing KM
J Vasc Access; 2019 Jan; 20(1):60-69. PubMed ID: 29893163
[TBL] [Abstract][Full Text] [Related]
8. A protocol of urokinase infusion and warfarin for the management of the thrombosed haemodialysis catheter.
Webb A; Abdalla M; Russell GI
Nephrol Dial Transplant; 2001 Oct; 16(10):2075-8. PubMed ID: 11572900
[TBL] [Abstract][Full Text] [Related]
9. Admixture of heparin with urokinase to decrease thrombolysis time and urokinase dose in polytetrafluoroethylene dialysis graft recanalization.
Harrell DS; Kozlowski M; Katz MD; Hanks SE
J Vasc Interv Radiol; 1996; 7(2):193-7. PubMed ID: 9007797
[TBL] [Abstract][Full Text] [Related]
10. Prevention of tunneled cuffed catheter dysfunction with prophylactic use of a taurolidine urokinase lock: A randomized double-blind trial.
Bonkain F; Stolear JC; Catalano C; Vandervelde D; Treille S; Couttenye MM; Dhondt A; Libertalis M; Allamani M; Madhoun P; Van Craenenbroeck AH; Vanommeslaeghe F; Van Hulle F; Durieux P; Van Limberghen I; Tielemans C; Wissing KM
PLoS One; 2021; 16(5):e0251793. PubMed ID: 34015014
[TBL] [Abstract][Full Text] [Related]
11. Dialysis graft declotting with very low dose urokinase: is it feasible to use "less and wait?".
Duszak R; Sacks D
J Vasc Interv Radiol; 1999 Feb; 10(2 Pt 1):123-8. PubMed ID: 10082097
[TBL] [Abstract][Full Text] [Related]
12. Natural saline-flush is sufficient to maintain patency of immobilized-urokinase double-lumen catheter used to provide temporary blood access for hemodialysis.
Kaneko Y; Iwano M; Yoshida H; Kosuge M; Ito S; Narita I; Gejyo F; Suzuki M
Blood Purif; 2004; 22(5):473-9. PubMed ID: 15523172
[TBL] [Abstract][Full Text] [Related]
13. Urokinase efficacy in the restoration of hemodialysis catheter function.
Meers C; Toffelmire EB
J CANNT; 1998; 8(2):17-9. PubMed ID: 9807329
[TBL] [Abstract][Full Text] [Related]
14. Synthetic dialysis shunts: thrombolysis with the Cragg thrombolytic brush catheter.
Dolmatch BL; Casteneda F; McNamara TO; Zemel G; Lieber M; Cragg AH
Radiology; 1999 Oct; 213(1):180-4. PubMed ID: 10540659
[TBL] [Abstract][Full Text] [Related]
15. Local intraarterial thrombolysis: in vitro comparison of various infusion catheters.
Froelich JJ; Hoppe M; Freymann C; Thiel T; Wagner HJ; Barth KH; Klose KJ
Cardiovasc Intervent Radiol; 1997; 20(5):369-76. PubMed ID: 9271648
[TBL] [Abstract][Full Text] [Related]
16. Prototype therapeutic ultrasound emitting catheter for accelerating thrombolysis.
Tachibana K; Tachibana S
J Ultrasound Med; 1997 Aug; 16(8):529-35. PubMed ID: 9315208
[TBL] [Abstract][Full Text] [Related]
17. High dose urokinase for restoration of patency of occluded permanent central venous catheters in hemodialysis patients.
Shavit L; Lifschitz M; Plaksin J; Grenader T; Slotki I
Clin Nephrol; 2010 Oct; 74(4):297-302. PubMed ID: 20875382
[TBL] [Abstract][Full Text] [Related]
18. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions.
Sugimoto K; Hofmann LV; Razavi MK; Kee ST; Sze DY; Dake MD; Semba CP
J Vasc Surg; 2003 Mar; 37(3):512-7. PubMed ID: 12618684
[TBL] [Abstract][Full Text] [Related]
19. Alteplase vs. urokinase for occluded hemodialysis catheter: A randomized trial.
Pollo V; DionÃzio D; Bucuvic EM; Castro JH; Ponce D
Hemodial Int; 2016 Jul; 20(3):378-84. PubMed ID: 26851872
[TBL] [Abstract][Full Text] [Related]
20. Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis.
Badylak SF; Voytik S; Klabunde RE; Henkin J; Leski M
Thromb Res; 1988 Nov; 52(4):295-312. PubMed ID: 3144052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
